Abstract
Health outcomes research is becoming increasingly important in evaluating health care. Because of limited resources, identifying health care services or interventions that produce value for money is essential. Clinical trials have become important venues for collecting outcomes data, and now, in addition to measuring clinical endpoints, they are being used for collecting economic and humanistic endpoints. Collection of outcomes data in clinical trials is beneficial for obtaining economic information necessary for timely drug approval and subsequent reimbursement, and for differentiating between the impact of treatment alternatives on the patient's health-related quality of life. Many factors contribute to the development of a comprehensive economic and quality of life assessment that will ultimately demonstrate the value of a given product or service.
Get full access to this article
View all access options for this article.